Skip to main content
. Author manuscript; available in PMC: 2018 Aug 15.
Published in final edited form as: J Immunol. 2017 Jul 10;199(4):1405–1417. doi: 10.4049/jimmunol.1700148

Table III. The top five up- and down-regulated chemokine and cytokine transcripts for each treatment condition.

Profiles were generated by contrasting treatment against negative controls. Positive FC indicates up-regulation, whereas negative (−) FC indicates down-regulation. Gray shaded boxes highlight the expression pattern of IFNα and IFNγ, whereas bold font highlights CXCL10 and IL-6 expression.

5′pppRNA-LyoVec (vs LyoVec only)
CD14+CD16− FC CD14+CD16+ FC CD14dimCD16+ FC
CXCL10 12.80 IFNA14 4.16 CCL8 4.43
IFNA14 9.32 IFNA16 4.12 CXCL10 2.18
IFNA16 8.49 IFNB1 3.64 IL1RN 2.04
IFNA2 8.30 CXCL10 3.31 CCR7 2.01
IFNB1 7.64 IL27 3.05 IFNB1 1.93

CCL24 −1.92 CCL24 −1.72 CCL24 −1.50
IL1B −2.16 IL1A −1.92 CCL1 −1.61
IL1A −2.32 IL1B −1.96 IL3RA −1.74
CXCL6 −2.55 CXCL5 −2.17 CXCL8 −1.76
CXCL5 −3.53 CCL1 −2.67 IL1B −2.39

LPS (vs NT)
CD14+CD16 FC CD14+CD16+ FC CD14dimCD16+ FC

IL23A 6.76 IL23A 12.98 IFNG 12.59
CCL22 4.96 IFNG 10.01 IL2RA 6.90
IL24 4.43 CCL20 6.55 IL6 5.08
IL6 4.22 IL24 6.17 IL1B 3.93
CCL3 3.30 IL6 4.77 CCR7 3.66

IL3RA −3.13 CXCL16 −4.15 IL18BP −8.19
CCL7 −3.36 CCL13 −5.41 CXCL10 −8.41
CCR1 −4.33 CCL2 −6.19 CXCL16 −9.86
CCL8 −7.99 CCL8 −8.80 CCL8 −10.88
CCL13 −10.45 CXCL10 −9.39 IL13RA1 −14.11

CLO97 (vs NT)
CD14+CD16 FC CD14+CD16+ FC CD14dimCD16+ FC

CCL22 4.34 IFNG 25.98 IFNG 12.69
IL6 3.80 IL18RAP 5.44 IL6 10.39
CXCL2 3.09 IL6 4.41 CCL19 6.08
CCL20 2.58 CXCR4 3.57 CCR7 5.38
CCL3 2.54 IL36G 3.47 IL2RA 4.79

CCR1 −2.78 IL7R −2.78 IL6R −3.59
CCL23 −3.00 IL13RA1 −2.93 IL3RA −3.70
IL18BP −3.48 IL18BP −2.96 IL18BP −4.77
CXCL10 −4.14 CCL13 −3.03 CXCL16 −5.30
CCL13 −4.21 CCL23 −7.18 IL13RA1 −6.88